PharmacyCodes



Nifuran en es it fr

Categorie

Nifuran Les marques, Nifuran Analogs

Nifuran Les marques melange

  • No information avaliable

    • Nifuran Formule chimique

    C8H6N4O5

    Nifuran RX lien

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Nifuran FDA fiche

    Nifuran msds (fiche de securite des materiaux)

    Nifuran MSDS

    Nifuran Synthese de reference

    Aucune information disponible

    Nifuran Poids moleculaire

    238.157 g/mol

    Nifuran Point de fusion

    263 oC

    Nifuran H2O Solubilite

    79,5 mg / L

    Nifuran Etat

    Solid

    Nifuran LogP

    -0.04

    Nifuran Formes pharmaceutiques

    Tablet

    Nifuran Indication

    Pour le traitement de l'infection des voies urinaires

    Nifuran Pharmacologie

    Nitrofurantoin, un nitrofurane agent antibactérien, est disponible sous forme microcristalline et macrocristallin pour traiter les infections des voies urinaires causées par de nombreuses bactéries gram-négatives et certaines bactéries Gram-positives.

    Nifuran Absorption

    Aucune information disponible

    Nifuran Toxicite

    Aucune information disponible

    Nifuran Information pour les patients

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Nifuran Organismes affectes

    Gram négatif et certaines bactéries Gram positives